Francesc Puchades Gimeno
A5014341161- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- Antibiotic Use and Resistance
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Venous Thromboembolism Diagnosis and Management
- Cystic Fibrosis Research Advances
- Dermatological and COVID-19 studies
- Nosocomial Infections in ICU
- Atrial Fibrillation Management and Outcomes
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Animal Ecology and Behavior Studies
- Cardiac Arrhythmias and Treatments
- Immunodeficiency and Autoimmune Disorders
- Ocular Diseases and Behçet’s Syndrome
- Health and Medical Education
- Autoimmune and Inflammatory Disorders
- Family and Patient Care in Intensive Care Units
- Vaccine Coverage and Hesitancy
- Public Health and Environmental Issues
- Antibiotics Pharmacokinetics and Efficacy
- Liver Disease Diagnosis and Treatment
- Streptococcal Infections and Treatments
Hospital General Universitario De Valencia
2007-2025
Hospital Universitari de Vic
2022-2023
Imation (United States)
2021
Valencia Catholic University Saint Vincent Martyr
2020
Hospital Universitario 12 De Octubre
2017
Research Institute Hospital 12 de Octubre
2017
Hospital Universitario Doctor Peset
2015-2016
Hospital Universitari i Politècnic La Fe
2007-2015
In patients with Candida parapsilosis candidemia, the use of an echinocandin-based regimen for first 72 hours therapy had no impact on odds clinical failure, despite lower in vitro activity this class antifungals.
ObjectiveParadoxical growth (PG) and trailing effect (TE) are frequently observed during antifungal susceptibility testing (AFST). These two phenomena interfere with the determination of minimal inhibitory concentration (MIC). The aim this study was to assess clinical impact TE PG.MethodsWe analysed frequency PG 690 Candida isolates collected from a population-based performed in Spain (CANDIPOP) correlated results outcome patients.ResultsAround 70% (484/690) exhibited azoles. tropicalis...
ABSTRACT Background Spain has been one of the countries most affected by COVID-19 pandemic. Objective To create a registry patients with hospitalized in order to improve our knowledge clinical, diagnostic, therapeutic, and prognostic aspects this disease. Methods A multicentre retrospective cohort study, including consecutive confirmed throughout Spain. Epidemiological clinical data, additional tests at admission seven days, treatments administered, progress 30 days hospitalization were...
Common variable immunodeficiency (CVID) constitutes a heterogenic group of primary disorders with wide-ranging clinical spectrum. CVID-associated non-infectious morbidity major challenge requiring full understanding its pathophysiology and importance global variability, especially considering the broad clinical, genetic, regional heterogeneity CVID disorders. This work aimed to develop nationwide, multicenter, retrospective study over 3-year period describing epidemiological, laboratory,...
BackgroundStatins have immunomodulatory properties and hinder Candida growth. However, it is unknown whether they may improve prognosis in patients with candidemia. We sought to determine the effect of prior statin use on clinical outcomes suffering Methods FindingsMulticenter cohort study hospitalized adults candidemia between 2005 2011 six hospitals Spain, Brazil Argentina. Of 326 candidemias, 44 (13.5%) occurred users 282 (86.5%) non-users. The median value APACHE II at diagnosis was...
Background: Describe the profile of patients with obesity in internal medicine to determine role adiposity and related inflammation on metabolic risk and, identify various “high-risk obesity” phenotypes by means a cluster analysis. This study aimed different profiles high-risk based Methods: Cross-sectional, multicenter project that included outpatients attended medicine. A total 536 were studied. The mean age was 62 years, 51% women. Patients recruited from departments over two weeks...
Infection by coronavirus type 2, which is the cause of severe acute respiratory syndrome (SARS-CoV-2), gives rise to thromboembolic complications, including cerebrovascular disease. Due hypercoagulable state that accompanies pregnancy, thrombotic risk in these patients may be particularly significant.We report case a 41-year-old woman, 34+1 weeks pregnant, diagnosed with bilateral interstitial pneumonia, caused disease 2019 (COVID-19). The patient presented failure, and so decision was made...